U.S. Hospitality Stock News

If you are wondering whether Flex shares still offer value after a strong run, this article walks through what the current price might be implying about the company. Flex recently closed at US$65.67, with a 7 day return of a 0.2% decline, a 30 day return of 3.0%, a year to date return of 3.1% and a 1 year return of 65.2%, while the 3 year return is very large and the 5 year return is also very large. Recent news coverage has tended to focus on Flex as an established player in electronics...

Teva Pharmaceutical Industries (NYSE:TEVA) received FDA acceptance of its New Drug Application for a once monthly long acting injectable olanzapine treatment for schizophrenia. The candidate is designed to remove the need for post injection monitoring, which could reduce treatment barriers for patients and providers. Teva also reported positive 44 week extension data for duvakitug in ulcerative colitis and Crohn’s disease, with sustained efficacy and tolerability. Teva enters this news...

Recent Performance Snapshot Huntington Bancshares (HBAN) has recently drawn investor attention as its shares trade around $17.28, with mixed short term returns, including a 1.5% gain over the past day and a small decline over the past week. See our latest analysis for Huntington Bancshares. While the 1-day share price return of 1.53% contrasts with a 3.41% decline over the past week, Huntington Bancshares still shows a 6.21% 90-day share price return and an 11.77% 1-year total shareholder...

Astronics (NasdaqGS: ATRO) reported record fourth quarter results with strong revenue and margin performance. The company highlighted progress on key defense and aerospace programs that support its guidance for 2026. Management pointed to a record backlog and solid demand trends as supports for its multiyear outlook. Astronics, trading at $78.84, has seen the share price rise 39.3% year to date and 295.4% over the past year. Over three and five years, the stock has delivered gains of...

Innoviva (NasdaqGS:INVA) received FDA approval for NUZOLVENCE, a first in class treatment for uncomplicated urogenital gonorrhea. The company announced a US$125 million share repurchase program alongside the approval. These updates point to meaningful shifts in Innoviva's specialty therapeutics focus and capital allocation approach. For you as an investor, NUZOLVENCE adds a new approved therapy to Innoviva's portfolio, aligning with its push in specialty therapeutics. Gonorrhea treatment is...

General American Investors Company, Inc. has reported its full-year 2025 results, posting revenue of US$24.31 million and net income of US$339.84 million for the year ended December 31, 2025. The contrast between relatively modest revenue and very large net income highlights how investment gains can significantly shape this closed-end fund’s financial profile. With this unusually wide gap between revenue and net income, we’ll explore what the latest earnings mean for General American...

LXP Industrial Trust has reported its fourth-quarter and full-year 2025 results, showing lower revenue but higher full-year net income, and confirmed it has repurchased 23,207,370 shares for US$223.45 million since its 2015 buyback authorization. Alongside earnings, the REIT issued 2026 guidance that pairs a wide net income range with much higher Adjusted Company FFO per share expectations, highlighting a growing gap between accounting profits and cash-flow-based performance metrics. We’ll...

Cipher Digital (CIFR) closed out FY 2025 with Q4 revenue of US$59.7 million and a basic EPS loss of US$1.85, alongside a net income loss of US$734.2 million. On a trailing 12 month basis, revenue was US$223.9 million and basic EPS stood at a loss of US$2.15. The company has seen quarterly revenue move from US$42.2 million in Q4 2024 to US$59.7 million in Q4 2025, while EPS shifted from US$0.05 to a loss of US$1.85 over the same period. This sets up a results season where investors will be...

Context for Provident Financial Services (PFS) Provident Financial Services (PFS) has attracted fresh attention after recent share price moves, with the stock roughly flat over the past day but showing mixed returns over the past week, month and past 3 months. See our latest analysis for Provident Financial Services. At a share price of US$21.91, Provident Financial Services has paired a softer 7 day share price return of 4.61% with a stronger 30 day gain of 6.41%. Its 1 year total...

Earlier this week, T1 Energy replaced its chief accounting officer following an immediate termination and expressed support for U.S. Treasury guidance that confirms its eligibility for Section 45X tax credits tied to its domestic solar supply chain plans. The combination of leadership change and reinforced access to key tax incentives has sharpened investor focus on T1 Energy’s governance and policy-linked business model. Next, we’ll examine how the Treasury’s foreign entity of concern...

In the fourth quarter of 2025, Wynn Resorts reported revenue of US$1,865.98 million and net income of US$100.03 million, while also declaring a US$0.25 per-share dividend and later confirming a cyberattack that exposed hundreds of thousands of employee records. The combination of weaker quarterly profitability, an ongoing data breach investigation, and a class-action lawsuit over alleged cybersecurity failures raises fresh questions about Wynn’s risk profile and operational resilience...

Tilray Brands has entered an exclusive multi year licensing deal with Carlsberg Group to produce, market, sell, and distribute Carlsberg, Carlsberg Elephant, and Kronenbourg 1664 beers in the U.S. The agreement covers all U.S. sales channels and is set to begin in January 2027. The move adds a new beer portfolio to Tilray's growing alcohol and lifestyle business. Ticker NasdaqGS:TLRY last closed at $7.83, with the share price showing a 3.3% gain over the past week but a 10.3% decline over...

Why EMCOR Group (EME) Is On Investors’ Radar Today EMCOR Group (EME) has attracted fresh attention after recent trading left the shares around $801.80, prompting investors to reassess the company’s fundamentals, recent returns, and valuation signals. See our latest analysis for EMCOR Group. While EMCOR Group’s share price eased slightly in the latest session, its 30-day share price return of 11.94% and year-to-date gain of 25.55% sit alongside a very large 5-year total shareholder return of...

In February 2026, MicroVision announced a series of senior secured zero-coupon convertible notes totaling US$43.0 million, including an exchange offer and new issuance of notes due March 1, 2028, alongside a business update and fireside chat on its lidar strategy. This refinancing shifts near-term repayment obligations and may give MicroVision more flexibility to pursue integration of recent lidar acquisitions and its broader technology roadmap. Next, we’ll examine how MicroVision’s new...

Automatic Data Processing (ADP) drew fresh attention after reporting fiscal Q2 2026 results that management described as solid, alongside NER Pulse data showing four straight weeks of strengthening U.S. private job gains. See our latest analysis for Automatic Data Processing. The solid Q2 update and ongoing NER Pulse job gains arrived after a 17.0% 30 day share price decline and a 29.7% one year total shareholder return drop, leaving longer term total shareholder return over five years at...

Intellia Therapeutics (NTLA) is in focus after a busy stretch, with Q4 2025 results exceeding earnings and revenue expectations, encouraging hereditary angioedema trial data, and an FDA clinical hold lifted on its partnered gene editing drug. See our latest analysis for Intellia Therapeutics. At a share price of $13.42, Intellia has seen a 49.28% 90 day share price return and a 45.71% year to date share price return. However, the 3 year total shareholder return of a 69.49% decline shows that...

Molina Healthcare (MOH) is back in focus after mixed fourth quarter results, earnings that missed expectations, multiple analyst downgrades, and a new shareholder law firm investigation into medical cost disclosures and growth assumptions. See our latest analysis for Molina Healthcare. That mixed fourth quarter and the string of downgrades have been reflected in the price, with a 30 day share price return of 27.6% decline and a year to date share price return of 18.4% decline. The 1 year...

Adeia Inc. recently reported fourth-quarter 2025 revenue of US$182.64 million and net income of US$73.71 million, delivering record full-year results and issuing 2026 GAAP revenue guidance of US$395.0 million to US$435.0 million alongside a quarterly dividend of US$0.05 per share. These results were supported by 26 new license agreements, including multi-year deals with companies such as Microsoft and Disney, as Adeia continues shifting its revenue mix toward OTT and semiconductor markets...

Charter Communications (NasdaqGS:CHTR) named Nick Jeffery as Chief Operating Officer, adding senior telecom leadership experience aimed at operational change. The company introduced its Invincible WiFi product, described as the industry’s first WiFi 7 service with integrated battery and 5G backup. Charter outlined a rural network buildout focused on fiber expansion to underserved areas. The company launched a pledge that highlights up to $1,000 in savings for new broadband and mobile...

Earlier this week, Advanced Energy Industries reported fourth-quarter 2025 results that exceeded earnings and revenue expectations, while Executive Vice President and General Counsel Vonne Elizabeth Karpinski sold 964.001 shares of common stock on February 23, 2026 under a pre-arranged trading plan. The stronger-than-expected quarter, highlighted by robust performance in semiconductor-related demand, has sharpened investor focus on how Advanced Energy’s power solutions are positioned within...

In recent days, Adaptive Biotechnologies received supportive research updates from TD Cowen, BTIG, and JPMorgan following the company’s strong Q4 results and improved outlook. Analysts emphasized growing community adoption of its clonoSEQ minimal residual disease testing and progress on new indications, underscoring Adaptive’s position within specialty laboratory diagnostics. Next, we’ll examine how this post‑earnings analyst optimism, particularly around clonoSEQ’s community adoption, may...

In February 2026, Teledyne FLIR OEM launched the Lepton XDS, an ITAR-free, dual-thermal-and-visible camera module that embeds its MSX edge-enhancement technology and Prism ISP software into a compact, low-power package for embedded, mobile, and industrial OEM applications. By combining radiometric thermal sensing, real-time thermal-visible fusion, and an industry-first RJPEG output in a SWaP-optimized module, Teledyne is pushing advanced imaging intelligence into space- and power-constrained...

Earlier this month, Polestar announced its largest model expansion to date, planning four new vehicles by 2028, while targeting low double-digit volume growth in 2026 and a 30% expansion of its retail network. The company also highlighted meaningful progress on sustainability and technology, including emissions cuts per vehicle and the climate-focused Polestar 0 program, supported by a recent US$700,000,000 funding raise. We’ll now examine how this expanded four-model rollout and retail...

Recently, PNC Financial Services Group announced the retirement of long-time executive Richard Bynum and promoted Stacy Juchno to chief corporate responsibility officer while elevating Mike Abriatis to general auditor and executive committee member, alongside unveiling new data products, community investments, lending deals and acquisition plans including an agreement to acquire FirstBank in Colorado and Arizona. Together with its new PNC Monthly Consumer Health Check and expanded affordable...